华领医药（02552）于2026年2月5日递交的月报显示，截至2026年1月31日，其注册股本为2,000,000,000股，面值每股USD0.001，注册股本总额保持USD2,000,000，较上月无变化。该公司已发行股份数为1,056,605,016股，报告期内未有新增发行或回购注销，股本结构保持稳定，同时未持有任何库藏股份。
月报亦披露公司期权计划方面：已有79,239,669份股份期权处于授出状态，当月无行使或失效记录，期末结存数量与上月保持一致。本月公司确认已满足相关公众持股量要求。该公告由公司秘书袁颍欣签署，并确认各项发行及授权均遵守香港联交所《上市规则》及适用法律规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.